S-095033

N/A

Report date: 2024/11/29 20:00:39
NME

Base Information

Drug NameS-095033
Drug Alias NameAG-270S-95033S-095033
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsSolid tumoursEsophageal Squamous Cell CarcinomaLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgios Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdir SarlInstitut De Recherches Internationales Servier
Active IndicationsN/A
Inactive IndicationsSolid tumoursEsophageal Squamous Cell CarcinomaLymphoma

Other Information

ATC CodeN/A
Related LinksN/A